483
Nanospectra Bioscience IncFDA 483 - Nanospectra Bioscience Inc - November 22, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Nanospectra Bioscience Inc, a sponsor in Houston, TX, revealed two significant observations. The firm failed to obtain updated financial disclosure information from participating investigators and did not ensure all investigators received consistent versions of the investigational plan. These issues indicate deficiencies in sponsor oversight of clinical investigations.
Open in Dashboard
ID · b77f3336-9379-482e-904a-357e9394faa2